Psychemedics Corporation
PMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $19,685 | $22,098 | $25,240 | $24,909 |
| % Growth | -10.9% | -12.4% | 1.3% | – |
| Cost of Goods Sold | $12,584 | $13,685 | $15,949 | $14,645 |
| Gross Profit | $7,101 | $8,413 | $9,291 | $10,264 |
| % Margin | 36.1% | 38.1% | 36.8% | 41.2% |
| R&D Expenses | $749 | $1,144 | $1,326 | $1,130 |
| G&A Expenses | $5,695 | $7,192 | $5,857 | $6,126 |
| SG&A Expenses | $8,245 | $10,190 | $9,048 | $8,925 |
| Sales & Mktg Exp. | $2,550 | $2,998 | $3,191 | $2,799 |
| Other Operating Expenses | $0 | $0 | $43 | $0 |
| Operating Expenses | $8,994 | $11,334 | $10,374 | $10,055 |
| Operating Income | -$1,893 | -$2,921 | -$1,083 | -$3,481 |
| % Margin | -9.6% | -13.2% | -4.3% | -14% |
| Other Income/Exp. Net | -$23 | -$517 | $43 | -$1,030 |
| Pre-Tax Income | -$1,916 | -$3,438 | -$1,040 | -$821 |
| Tax Expense | -$55 | $716 | $44 | -$156 |
| Net Income | -$1,861 | -$4,154 | -$1,084 | -$665 |
| % Margin | -9.5% | -18.8% | -4.3% | -2.7% |
| EPS | -0.32 | -0.72 | -0.19 | -0.12 |
| % Growth | 55.6% | -278.9% | -58.3% | – |
| EPS Diluted | -0.32 | -0.72 | -0.19 | -0.12 |
| Weighted Avg Shares Out | 5,867 | 5,740 | 5,626 | 5,549 |
| Weighted Avg Shares Out Dil | 5,867 | 5,740 | 5,626 | 5,549 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $49 |
| Interest Expense | $26 | $17 | $0 | $49 |
| Depreciation & Amortization | $2,081 | $2,670 | $3,316 | $3,690 |
| EBITDA | $191 | -$751 | $2,233 | $3,899 |
| % Margin | 1% | -3.4% | 8.8% | 15.7% |